Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Prabhat Jha starts as new Head of Department

Professor Prabhat Jha has started in the role of Head of Department, taking over from Professor Sir Rory Collins who was Head of Department from its inception in 2013.

National registry launched to transform care for people at risk of type 1 diabetes

A first-of-its-kind UK registry for children and adults who are at risk of type 1 diabetes has been launched at the University of Oxford.

First myeloma patient joins Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science trial of radioactive bone scan

In a world first researchers at NDORMS are testing a new technology that could enable clinicians to better diagnose and treat myeloma.

Trial shows that suture repair fails to improve digital nerve injury outcomes

The first ever trial of microsurgical suture repair vs nerve alignment for digital nerve injuries suggests suture repair does not improve outcomes.

Iron Levels Found to Play a Key Role in FLASH Radiotherapy’s Tissue-Sparing Effect

Researchers in the Department of Oncology have uncovered new insights into how FLASH radiation therapy kills cancer cells while minimising damage to healthy tissues. Published in Cell Death & Disease, the study shows the key role of iron levels in FLASH radiotherapy's tissue-sparing effect.

New recommendations from the ongoing national enquiries into maternal health and care in the UK

The MBRRACE-UK collaboration, co-led by Oxford Population Health’s National Perinatal Epidemiology Unit, has today published the full Saving Lives, Improving Mothers’ Care report on women who died during or up to a year after pregnancy between 2021 and 2023.

Body-in-a-chip approach reveals how immune cells respond to heart injury

Oxford scientists build a connected, ‘multi-organoid’ platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.

World Suicide Prevention Day: latest research

The Centre for Suicide Research investigates the extent, nature and causes of self-harm and suicide, with the aim of translating the findings into implications for prevention, treatment and support.

New Study Evaluates Effectiveness of Cancer Diagnosis Pathway for Patients with Non-Specific Symptoms

A major UK study, led by researchers at the University of Oxford’s Nuffield Department of Primary Care Health Sciences, Oxford University Hospitals NHS Foundation Trust, the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre, and Oxford Cancer, has provided the most comprehensive analysis to date of a cancer diagnosis pathway for patients presenting with non-specific symptoms (NSS), such as unexplained weight loss or fatigue.

High blood pressure in midlife is associated with an increased risk of vascular dementia

Evidence from the Million Women Study has shown that women who have hypertension (high blood pressure) in their 50s or 60s are at increased risk of developing vascular dementia in their 70s or 80s. The study is published in Alzheimer’s and Dementia.

Long-term trial results show surgery and stenting are equally protective against stroke

Long-term results from the largest randomised trial of stenting and surgery have shown that the procedures are equally protective against stroke resulting from carotid artery disease.

New research identifies Galectin-3 as a key regulator of neural development, establishing its contribution to brain growth

Luana Soares, Francis Szele and colleagues from Oncology (Eric O’Neill), from Paediatrics (Mathew Wood) and from DPAG (Zoltan Molnar, Mootaz Salman), have identified Galectin-3 as a key regulator of neural development, establishing its contribution to brain growth.

Outstanding early-career researchers awarded European Research Council funding to launch their ideas

Today, eleven researchers at the University of Oxford have been selected to receive prestigious European Research Council (ERC) Starting Grants, each worth €1.5 million for a period of up to five years.

Research finds therapeutic potential for PEPITEM in osteoporosis

Researchers have identified bioactive peptide sequences in PEPITEM molecules, and demonstrated the biological activity of the full PEPITEM molecule in counteracting key changes caused by osteoporosis.

New ‘off-the-shelf’ immunotherapy shows promise for treating high-risk childhood leukaemia

Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for infants and children with high-risk leukaemia.

Oxford launches major new AI vaccine research programme with the Ellison Institute of Technology

The University of Oxford, through its strategic partnership with the Ellison Institute of Technology (EIT), has received research funding of £118m to launch an ambitious new programme of vaccine research.

Digital CBTe: A promising digital treatment for binge eating

An innovative digital treatment programme for binge eating, Digital CBTe, has shown significant benefits in multiple pilot studies.

New studies reveal optimal time intervals for COVID-19 vaccine boosters

Two new papers from scientists in the Nuffield Department of Medicine and other University of Oxford institutions have shown how the immune system reacts differently depending on the length of interval between vaccine doses.

The Kaiya Foundation to fund leukaemia research at University of Oxford

The Kaiya Foundation has awarded one of its first major research grants, which will fund pioneering research into the fundamental cause of a high-risk leukaemia. The grant is being made to Dr Emily Neil and Professor Anindita Roy from the Childhood Leukaemia Research Group, based at the University of Oxford, in the hope that their discoveries will transform treatment approaches for sufferers through personalised medicine.

Teenage period pain linked to higher risk of chronic pain in adulthood

Teenagers who experience moderate or severe period pain are significantly more likely to develop chronic pain in adulthood – including pain beyond the pelvis – according to a major new study from the University of Oxford, funded by the Medical Research Foundation.

Load More